-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RJrlfqvkYAnvz5c5uuyRbVlne8hqrFl3+WgQ+RhNbCo52EkQbd+fl51i79BQ62ub 2CYGff0A3XUntU3BWsFkzw== 0000810084-10-000006.txt : 20100212 0000810084-10-000006.hdr.sgml : 20100212 20100212200413 ACCESSION NUMBER: 0000810084-10-000006 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091231 FILED AS OF DATE: 20100212 DATE AS OF CHANGE: 20100212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 5036928001 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STOUT RICHARD CENTRAL INDEX KEY: 0001200163 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 10601951 MAIL ADDRESS: STREET 1: 27474 MOUNTAIN ROAD CITY: WEST LINN STATE: OR ZIP: 97068 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0303 4/A 2009-12-31 2010-01-04 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001200163 STOUT RICHARD 20245 SW 95TH AVENUE TUALATIN OR 97062 0 1 0 0 EVP/Chief Medical Officer BJCT Common Stock 2009-12-31 4 M 0 25000 0 A 353341 D BJCT Common Stock 110964 I 401(K) Restricted Stock Unit 2009-12-31 4 M 0 25000 0 D 2009-12-31 BJCT Common Stock 25000 115331 D This amendment is to add an additional 25,000 shares that should have been included in the Form 4 filed on January 4, 2010. Vesting pursuant to the Restricted Stock Ageement dated January 30, 2008. Includes 17,660 shares received for Q4 2009 401(K) Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock. No expiration date. Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 40,231 Restricted Stock Unit 64,000. //Christine M. Farrell Attorney-in-Fact for Richard R. Stout// 2010-02-12 -----END PRIVACY-ENHANCED MESSAGE-----